Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Champion |
Description | Amyotrophic Lateral Sclerosis --> Amyotrophic Lateral Sclerosis (ALS) For Healthcare Professionals What is ALS? Amyotrophic Lateral Sclerosis (ALS) is a rare neurological disorder o |
Keywords | N/A |
WebSite | alschampion.com |
Host IP | 162.241.219.110 |
Location | United States |
Site | Rank |
US$1,274
Last updated: 2022-12-03 19:39:16
alschampion.com has Semrush global rank of 0. alschampion.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. alschampion.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 162.241.219.110. According to SiteAdvisor, alschampion.com is safe to visit. |
Purchase/Sale Value | US$1,274 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$35 |
Yearly Ads Revenue | US$423 |
Daily Unique Visitors | 9 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
alschampion.com. | A | 14399 | IP: 162.241.219.110 |
alschampion.com. | NS | 21600 | NS Record: ns1.bluehost.com. |
alschampion.com. | NS | 21600 | NS Record: ns2.bluehost.com. |
alschampion.com. | MX | 14400 | MX Record: 0 mail.alschampion.com. |
alschampion.com. | TXT | 14400 | TXT Record: v=spf1 a mx include:websitewelcome.com ~all |
--> Amyotrophic Lateral Sclerosis (ALS) For Healthcare Professionals What is ALS? Amyotrophic Lateral Sclerosis (ALS) is a rare neurological disorder of progressive deterioration of nerve cells (motor neurons) in the brain and the spinal cord that control muscles throughout the body. When nerve cells die or deteriorate, the brain can no longer control muscle movement, and people with ALS may lose the ability to speak, eat, move and breathe. The causes of ALS are largely unknown, but inflammation may play a role. Complement is a part of the immune system and helps your body fight infections. Overactive complement may play a role in ALS through damage to the motor neurons and the activation of inflammation. --> --> < > ID: NCT04248465 The purpose of this clinical study is to assess the safety and efficacy of ravulizumab-cwvz in adults with ALS. Ravulizumab-cwvz is not currently FDA-approved for the treatment of ALS but is being investigated in the CHAMPION ALS study. |
HTTP/1.1 200 OK Date: Tue, 28 Jun 2022 09:06:11 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Last-Modified: Wed, 20 Jan 2021 23:20:50 GMT Accept-Ranges: bytes Content-Length: 19784 Vary: Accept-Encoding host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ== Content-Type: text/html |
Domain Name: ALSCHAMPION.COM Registry Domain ID: 2466169801_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.google.com Registrar URL: http://domains.google.com Updated Date: 2021-12-12T00:45:21Z Creation Date: 2019-12-11T21:52:51Z Registry Expiry Date: 2022-12-11T21:52:51Z Registrar: Google LLC Registrar IANA ID: 895 Registrar Abuse Contact Email: registrar-abuse@google.com Registrar Abuse Contact Phone: +1.8772376466 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BLUEHOST.COM Name Server: NS2.BLUEHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2022-06-28T09:09:24Z <<< |